Drugs & Targets FDA gives priority review to BMS Empliciti + pomalidomide, dexamethasone in multiple myeloma September 07, 2018Vol.44 No.33
Drugs & Targets Rafael Pharmaceuticals receives FDA Orphan Drug Designation of CPI-613 for peripheral T-cell lymphoma September 07, 2018Vol.44 No.33
Clinical Roundup SOLAR-1 trial of Novartis meets primary endpoint in HR+/HER2- advanced breast cancer September 07, 2018Vol.44 No.33
Clinical Roundup PARP inhibitor improves progression-free survival in patients with advanced breast cancers and BRCA mutations September 07, 2018Vol.44 No.33
Clinical Roundup NCI-led research team develops predictor for immunotherapy response in melanoma September 07, 2018Vol.44 No.33
Clinical Roundup Cetuximab + radiation found inferior to standard treatment in HPV-positive oropharyngeal cancer September 07, 2018Vol.44 No.33
Clinical Roundup Secondhand smoke exposure in childhood may raise risk of adult lung disease September 07, 2018Vol.44 No.33
Clinical Roundup Mount Sinai researchers create RNA and DNA-sequencing platform to match broader swath of cancer drugs September 07, 2018Vol.44 No.33
Clinical Roundup Duke researchers find missing immune cells that could fight lethal brain tumors September 07, 2018Vol.44 No.33
